首頁 > 市場調查報告書 > 製藥

3D列印

市場調查報告書

商品編碼

1352945

全球 3D 列印藥品市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢與預測

Global 3D Printed Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年09月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計到 2030 年，全球 3D 列印藥品市場的市場規模將從 2022 年的 77.27 萬美元達到近 328.36 萬美元，2023-2030 年研究期間複合年成長率為 17.44%。

3D列印藥物是透過3D列印技術為個人量身訂製的藥物，以提高安全性和有效性。 3D 列印藥物具有單一的多孔結構，容易在口腔中分散，因此這些高劑量藥物無需完整吞嚥。

市場動態：

可在口腔中輕鬆分散的速溶藥物的需求增加是推動全球3D列印藥物市場成長的主要因素之一。此外，吞嚥困難盛行率的增加、醫療保健行業中 3D 列印技術的使用增加、個人化藥物的採用增加以及組合藥物的生產促進了市場的成長。此外，人們對藥物優勢的認知不斷提高，例如老年人、嬰兒和患有癲癇等癲癇等癲癇病的患者易於服用藥物，將確保預測期內的高需求。此外，發展中國家醫療基礎設施的改善和技術進步被認為是影響未來幾年3D列印藥品市場發展的因素。然而，缺乏與 3D 列印藥物相關的政府法規以及 3D 列印藥物的有害影響可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球 3D 列印藥物市場的各個細分市場進行了包容性評估。 3D 列印藥品產業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲 3D 列印藥物市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 3D列印藥物市場的主要參與者包括Aprecia、Formac Pharmaceuticals、Extend Biosciences、Affinity Therapeutics、Osmotica Pharmaceuticals、GSK Group of Companies、FabRx Ltd.、Hewlett Packard Caribe、Merck & Co. Inc.、Cycle Pharmaceuticals、阿斯特捷利康。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望銷售分析
簡介銷售分析
北美銷售分析
- 概述、歷史和預測銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：3D 列印藥品公司的競爭格局

3D列印藥品市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

十大公司股票分析
市場集中度
Aprecia

公司簡介
公司收入
產品
最近的發展

Formac Pharmaceuticals

公司簡介
公司收入
產品
最近的發展

Extend Biosciences

公司簡介
公司收入
產品
最近的發展

Affinity Therapeutics

公司簡介
公司收入
產品
最近的發展

Osmotica Pharmaceuticals

公司簡介
公司收入
產品
最近的發展

GSK Group of Companies

公司簡介
公司收入
產品
最近的發展

FabRx Ltd.

公司簡介
公司收入
產品
最近的發展

Hewlett Packard Caribe

公司簡介
公司收入
產品
最近的發展

Merck & Co. Inc.

公司簡介
公司收入
產品
最近的發展

Cycle Pharmaceuticals

公司簡介
公司收入
產品
最近的發展

AstraZeneca.

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR11218808

The global demand for 3D Printed Drugs Market is presumed to reach the market size of nearly USD 328.36 MN by 2030 from USD 77.27 MN in 2022 with a CAGR of 17.44% under the study period 2023 - 2030.

3D printed drugs are medications designed by 3D printing techniques to customize for individuals for more safety and effectiveness. 3D printed drugs have unitary porous structures that readily disperse in the mouth, as a result of which these high-dose medicines need not be swallowed intact.

MARKET DYNAMICS:

The increase in demand for instantaneous soluble drugs that can disperse easily in the mouth is one of the main factors that drive the growth of the global 3D printed drugs market. Moreover, an increase in the prevalence of dysphagia, a rise in usage of 3D printing techniques in the medical & healthcare industries, an increase in the adoption of personalized drugs, and the production of combination medicine boost the market growth. Furthermore, a rise in awareness about the advantages of the drugs, such as ease of intake of the drugs for the elderly, infants, and patients suffering from seizures-causing diseases such as epilepsy will ensure high demand under the projection period. Additionally, improvement in healthcare infrastructure and technological advancements in developing countries are the factors that are believed to influence the development of the 3D printed drugs market in upcoming years. However, the absence of government regulations related to 3D printed drugs and the harmful effects of 3D printed drugs may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of 3d printed drugs. The growth and trends of 3d printed drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the 3d printed drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

Inkjet Printing
Fused Deposition Modeling
Stereolithography
Zipdose Technology

By Application

Orthopedic
Neurology
Dental
Others

By End-Use

Hospitals & Clinics
Research Laboratories
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the 3D Printed Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the 3d printed drugs market include Aprecia, Formac Pharmaceuticals, Extend Biosciences, Affinity Therapeutics, Osmotica Pharmaceuticals, GSK Group of Companies, FabRx Ltd., Hewlett Packard Caribe, Merck & Co. Inc., Cycle Pharmaceuticals, AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . 3D PRINTED DRUGS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL 3D PRINTED DRUGS MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Inkjet Printing Historic and Forecast Sales by Regions
6.5 Fused Deposition Modeling Historic and Forecast Sales by Regions
6.6 Stereolithography Historic and Forecast Sales by Regions
6.7 ZipDose Technology Historic and Forecast Sales by Regions

7 . GLOBAL 3D PRINTED DRUGS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Orthopedic Historic and Forecast Sales by Regions
7.5 Neurology Historic and Forecast Sales by Regions
7.6 Dental Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL 3D PRINTED DRUGS MARKET SALES ANALYSIS BY END-USE

8.1 Overview by End-use
8.2 Historical and Forecast Data
8.3 Analysis by End-use
8.4 Hospitals & Clinics Historic and Forecast Sales by Regions
8.5 Research Laboratories Historic and Forecast Sales by Regions
8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL 3D PRINTED DRUGS MARKET SALES ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook Sales Analysis
9.2. Introduction Sales Analysis
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE 3D PRINTED DRUGS COMPANIES

10.1. 3D Printed Drugs Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF 3D PRINTED DRUGS INDUSTRY

11.1. Top 10 Company Share Analysis
11.2. Market Concentration Rate
11.3. Aprecia
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Formac Pharmaceuticals
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. Extend Biosciences
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Affinity Therapeutics
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Osmotica Pharmaceuticals
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. GSK Group of Companies
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. FabRx Ltd.
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Hewlett Packard Caribe
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Merck & Co. Inc.
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Cycle Pharmaceuticals
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. AstraZeneca.
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments